My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 395

    1.

    Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.

    Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J.

    Arthritis Res Ther. 2008;10(5):R125. Epub 2008 Oct 22.

    PMID:
    18945353
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.

    Woo JH, Lee HJ, Sung IH, Kim TH.

    J Rheumatol. 2007 Aug;34(8):1753-9. Epub 2007 Jun 15.

    PMID:
    17610317
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].

    Yang CH, Huang F, Deng XH, Zhang JL, Zhang LY, Guo JH, Liang DF, Wang LS, Zhang YM.

    Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4. Chinese.

    PMID:
    17156669
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.

    Pedersen SJ, Sørensen IJ, Lambert RG, Hermann KG, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M.

    Arthritis Rheum. 2011 Dec;63(12):3789-800. doi: 10.1002/art.30627.

    PMID:
    22127697
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy.

    Wendling D, Cedoz JP, Racadot E.

    Joint Bone Spine. 2008 Oct;75(5):559-62.

    PMID:
    18674944
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.

    Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC Jr.

    J Rheumatol. 2005 Oct;32(10):1911-7.

    PMID:
    16206346
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors.

    Pedersen SJ, Hetland ML, Sørensen IJ, Ostergaard M, Nielsen HJ, Johansen JS.

    Clin Rheumatol. 2010 Nov;29(11):1301-9. Epub 2010 Jul 18.

    PMID:
    20640910
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.

    Maksymowych WP, Rahman P, Shojania K, Olszynski WP, Thomson GT, Ballal S, Wong RL, Inman RD; M03-606 Study Group.

    J Rheumatol. 2008 Oct;35(10):2030-7. Epub 2008 Sep 1.

    PMID:
    18785308
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.

    Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.

    Ann Rheum Dis. 2011 Aug;70(8):1375-81. Epub 2011 May 8.

    PMID:
    21551511
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    [Clinical study of etanercept for treating ankylosing spondylitis].

    Liang LQ, Zhan ZP, Ye YJ, Fu D, Xu HS, Yang XY.

    Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(8):1349-51. Chinese.

    PMID:
    18753057
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?

    Maksymowych WP.

    Arthritis Res Ther. 2009;11(1):101. Epub 2009 Jan 7.

    PMID:
    19183433
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    12.

    Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.

    Maksymowych WP, Jhangri GS, Lambert RG, Mallon C, Buenviaje H, Pedrycz E, Luongo R, Russell AS.

    J Rheumatol. 2002 May;29(5):959-65.

    PMID:
    12022358
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Cytokine profiles during infliximab monotherapy in psoriatic arthritis.

    Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Berardesca E.

    Br J Dermatol. 2005 Sep;153(3):531-6.

    PMID:
    16120138
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

    Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D.

    Arthritis Rheum. 2007 Jun;56(6):1846-53.

    PMID:
    17530713
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    15.

    Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?

    Haibel H, Sieper J.

    Curr Opin Rheumatol. 2010 Jul;22(4):388-92. Review.

    PMID:
    20473176
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.

    Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.

    Arthritis Rheum. 2005 Mar;52(3):885-91.

    PMID:
    15751093
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    17.

    Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

    van der Heijde D, Salonen D, Weissman BN, Landewé R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R; Canadian (M03-606) study group; ATLAS study group.

    Arthritis Res Ther. 2009;11(4):R127. Epub 2009 Aug 24.

    PMID:
    19703304
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.

    Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK.

    Rheumatology (Oxford). 2008 Dec;47(12):1775-9. Epub 2008 Oct 14.

    PMID:
    18854347
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    19.

    Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.

    Aref S, Salama O, Shamaa S, El-Refaie M, Mourkos H.

    Hematology. 2007 Aug;12(4):319-24.

    PMID:
    17654059
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.

    Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J.

    Arthritis Res Ther. 2008;10(5):R104. Epub 2008 Sep 1.

    PMID:
    18761747
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk